American Heart Association - You’re the Cure

LoginLogin with Facebook

Remember me Forgot Password

Be the Cure, Join Today!

  • Learn about heart-health issues
  • Meet other likeminded advocates
  • Take action and be heard

What's on Tap for VA Session

by Keltcie D. on Tuesday, December 17, 2013







 Happy New Year!  The new state General Assembly session (beginning Jan 8), promises to be an important one for VA citizens.  With a number of key issues expected on the docket, You’re the Cure advocates will have opportunities to help drive significant advances critical to cardiovascular diseases and stroke. 

Here’s a quick look at several policy areas already on tap:

  • Expand Critical Congenital Heart Defect Screening in Newborns – advocate to ensure that every newborn in Virginia receives a pulse oximetry screening from a birthing facility before discharge.  It’s fast, inexpensive, noninvasive, and saves babies lives.

Tell your legislators every baby deserves this life-saving diagnostic test.

  • Promote Access to Health Coverage – Support Medicaid coverage of cessation services for current tobacco users.  Virginia’s Medicaid program spends more than $401 million annually on smoking related illnesses.  Every dollar spent for Medicaid cessation results in $1.25 in savings in health care cost for the state.   

We also anticipate working on healthy food procurement in state agencies, availability of healthy foods in VA communities, and monitoring opportunities for health reform.  As always, new issues could emerge that we will engage in or follow, and we’ll keep you posted about those we need your voice on.   

Want a little more scoop?  It’s not too late to register for our short call scheduled for Friday Jan 10 from 12:30 to 1:00pm to discuss what’s unfolding for your state session.

Click here to register for the call!

Call-in information will be provided to those registered before the call. 

Take action NOW to urge support for pulse oximetry screening for babies.


Leave a Comment

Comments (0)

  • Be the first to respond!

[+] Comments